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Abstract
Neurogenesis in the adult hippocampus involves activation of quiescent neural stem cells (NSCs) 
to yield transiently amplifying NSCs and progenitors, and ultimately neurons that affect learning 
and memory. This process is tightly controlled by microenvironmental cues, though few 
endogenous factors are known to regulate neuronal differentiation. While astrocytes have been 
implicated, their role in juxtacrine (i.e. cell-cell contact-dependent) signaling within NSC niches 
has not been investigated. We show that ephrin-B2 presented from rodent hippocampal astrocytes 
regulates neurogenesis in vivo. Furthermore, clonal analysis in NSC fate-mapping studies reveals a 
novel role for ephrin-B2 in instructing neuronal differentiation. Additionally, ephrin-B2 signaling, 
transduced by EphB4 receptors on NSCs, activates β-catenin in vitro and in vivo independent of 
Wnt signaling and upregulates proneural transcription factors. Ephrin-B2+ astrocytes thus promote 
neuronal differentiation of adult NSCs through juxtacrine signaling, findings that advance our 
understanding of adult neurogenesis and may have future regenerative medicine implications.
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In the mammalian brain, neurogenesis persists throughout adulthood in the subgranular zone 
(SGZ) of the hippocampal dentate gyrus1 and the subventricular zone (SVZ) of the lateral 
ventricles2. Within these niches, neural stem cell (NSC) maintenance, proliferation, and 
differentiation are orchestrated by a delicate balance of microenvironmental cues. The 
importance of such instructive signals in the niche is supported by the absence of significant 
neurogenesis in the adult mammalian central nervous system (CNS) outside of these 
regions3,4 and by the development of aberrant neurogenesis in patients with pathologies that 
disrupt the natural chemistry of the brain, for example epilepsy5, inflammation6, and 
neurodegenerative diseases7.
In the SGZ, adult neurogenesis entails the activation of quiescent Type 1 NSCs to produce 
mitotic, multipotent Type 2a NSCs8,9; the differentiation of the Type 2a NSCs to lineage-
committed, proliferative Type 2b neuronal precursors and subsequently Type 3 neuroblasts; 
and the survival, migration, and maturation of neuroblasts as they differentiate into granule 
cells that synaptically integrate into the existing neural network8–10. Each of these stages is 
regulated by signals within the niche. For example, bone morphogenic protein11 and 
Notch12,13 signaling modulate the balance between quiescent and proliferative NSCs, and 
Sonic hedgehog14, fibroblast growth factor-215, vascular endothelial growth factor16, and 
Wnt7a17 regulate NSC proliferation.
While there is thus increasing knowledge of niche factors that regulate NSC division, 
significantly less is known about key signals that instruct cells in the SGZ to undergo 
neuronal differentiation18,19. Gamma aminobutyric acid (GABA) inputs from local neuronal 
circuitry20 and systemic retinoic acid levels21 modulate NSC neuronal fate commitment. 
Furthermore, while neuronal differentiation precedes gliogenesis during CNS development, 
adult hippocampal astrocytes directly induce neuronal differentiation of NSCs in vitro via 
both secreted and membrane-associated factors22, and the former have since been found to 
include Wnt3a23 and potentially additional secreted signals19. However, the membrane-
bound astrocytic components22 that may play critical roles in neuronal fate commitment in 
vivo remain unidentified.
Ephrins are a diverse class of glycophosphatidylinositol-linked (ephrinA1–6) and 
transmembrane (ephrinB1–3) cell surface ligands that bind Eph receptors (EphA1–10 and 
EphB1–6) on opposing cell membranes to initiate bidirectional signaling24. Ephrin/Eph 
signaling is traditionally known to control the spatial organization of cells and their 
projections by modulating intercellular attractive and repulsive forces25. For example, 
ephrin/Eph signaling instructs topographical mapping of hippocampo-septal and entorhino-
hippocampal projections during development26 and regulates neuronal dendrite spine 
morphogenesis and synaptogenesis of adult hippocampal neurons27.
Recent studies have also indicated that ephrin/Eph signaling plays an earlier role in 
regulating stem cell behavior. For example, ephrin-A/EphA signaling promotes embryonic 
telencephalic NSC differentiation28, and ephrin-B3/EphB3 signaling may exert an anti-
proliferative effect on NSCs in the developing SVZ29. Within the adult CNS, infusion of 
ephrin-B2 or EphB2 ectodomains into the lateral ventricles induced SVZ NSC proliferation 
and disrupted neuroblast migration through the rostral migratory stream30. Also, signaling 
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between ephrin-A2+ neural stem cells, and EphA7+ ependymal cells and putative stem cells, 
was shown to suppress proliferation of NSCs in the adult SVZ31. Within the adult SGZ, 
ephrin-B3+ neurons in the granule cell layer have been proposed to regulate EphB1+ NSC 
polarity, SGZ positioning, and proliferation32. Similarly, in Efna5−/− mice, a decrease in 
both the proliferation of NSCs and the survival/maturation of newborn neurons in the adult 
SGZ was observed33. Thus, ephrin/Eph signaling has been shown to affect the proliferation, 
migration, and survival of adult NSCs; however, its potential regulation of NSC fate 
commitment remains unknown.
Here, we demonstrate that ephrin-B2 presented by hippocampal astrocytes instructs neuronal 
differentiation of NSCs in the SGZ of the adult hippocampus. Furthermore, ephrin-B2/
EphB4 forward signaling induces neuronal differentiation of NSCs by activating β-catenin, 
independent of Wnt signaling, and inducing transcription of proneural transcription factors. 
Thus, these findings describe a novel juxtacrine signaling mechanism by which astrocytes 
actively regulate neuronal differentiation of NSCs during adult neurogenesis.
Results
Ephrin-B2 and EphB4 expression in the SGZ
In the SGZ, Type 1 NSCs express the SRY-box 2 (Sox2) transcription factor and stain for 
glial fibrilary acid protein (GFAP) and Nestin along radial granule cell layer (GCL)-
spanning or horizontal processes13. Type 2a NSCs9 remain Sox2+ and Nestin+ but 
downregulate GFAP expression, and fate-restricted, proliferative Type 2b neuronal 
precursors co-express Sox2 and doublecortin (DCX) while downregulating Nestin 
expression. The latter then mature into (Sox2−/DCX+) Type 3 neuroblasts, which migrate 
into the GCL to become neuronal specific nuclear protein (NeuN)-positive/DCX− granule 
neurons8,10,11,13. Alternatively, Type 1 NSCs can differentiate into stellate, Sox2−/GFAP+, 
hippocampal astrocytes primarily located in the hilus adjacent to the SGZ10.
As part of a candidate screen, we investigated ephrin-B2 expression within the hippocampal 
dentate gyrus. Ephrin-B2 antibodies consistently labeled GFAP+ astrocytes in the hilus, the 
SGZ, and the molecular layer (Fig. 1a,b). In contrast, EphB4, an ephrin-B2 receptor, was 
expressed by Sox2+/DCX−, Sox2+/DCX+, Sox2−/DCX+, and Sox2+/GFAP− cells in the 
SGZ, as well as on the majority of cells in the GCL (Fig. 1a,c,d). Therefore, EphB4 appears 
to be expressed in Type 2a (Sox2+/DCX−/GFAP−) NSCs and persists as these cells become 
Type 2b neuronal precursors (Sox2+/DCX+), Type 3 neuroblasts (Sox2−/DCX+), and 
eventually granule neurons. Some Type 1 NSCs stained EphB4+, though in many EphB4 
was not expressed at levels detectable by immunostaining (data not shown). Overall, 
staining results indicate that astrocytes are a source of ephrin-B2 ligand in the dentate gyrus 
and suggest that EphB4-expressing NSCs, neuronal precursors, and neuroblasts contact 
these ligand-expressing astrocytes (Fig. 1e,f).
Ephrin-B2 increases neurogenesis in vitro and in vivo
Ephrin/Eph signaling begins with clustering of multiple ligand-receptor complexes at sites 
of cell-cell contact24. Thus to initially explore a possible role for ephrin-B2 in regulating 
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NSC fate, antibody-clustered ephrin-B2/Fc fusion molecules (Fc-ephrin-B2)34 were added 
to adult hippocampus-derived NSCs in culture and found to induce a strong, dose-dependent 
increase in NSC neuronal differentiation (Fig. 2a,b). No biological activity was observed 
with monomeric, unclustered ephrin-B2/Fc, consistent with previous findings30,34, and no 
proliferative effect was observed under any conditions (data not shown). To investigate 
which receptor mediated Fc-ephrin-B2’s activity, the NSCs were pre-incubated with an 
antibody against EphB2 or EphB4, two known ephrin-B2 receptors, before addition of Fc-
ephrin-B2. Inhibition of EphB4, but not EphB2, significantly reduced Fc-ephrin-B2 
induction of neuronal differentiation (Fig. 2c), indicating that EphB4 receptors mediate the 
proneuronal effect of Fc-ephrin-B2. RT-PCR and immunocytochemistry (ICC) results 
confirmed that hippocampus-derived NSCs express EphB4 receptors (Fig. 2d), in contrast to 
SVZ NSCs which reportedly do not express EphB430.
Given the previous staining and in vitro results, we hypothesized that astrocytic ephrin-B2 
actively promotes neuronal differentiation of NSCs in the SGZ through juxtacrine signaling, 
and therefore, we proceeded to investigate Fc-ephrin-B2 activity in vivo. Mitotic cells in the 
brain of adult rats were first labeled with BrdU, followed by bilateral hippocampal injections 
of PBS, non-clustered ephrin-B2, Anti-Fc antibody without ephrin-B2, or Fc-ephrin-B2 
(Fig. 3a). Five days after injection, histology showed an increase in the number of BrdU+ 
cells in the SGZ of animals injected with Fc-ephrin-B2 compared to animals treated with 
vehicle or clustering antibody controls (Fig. 3c), mirroring one report in the SVZ30. In 
addition, no difference in the percentage of BrdU+ cells that co-stained as non-radial GFAP+ 
astrocytes was observed between experimental groups at Day 5 (Supplementary Fig. 1a,b). 
However, there was a considerable increase in the proportion of BrdU+ cells that co-stained 
for DCX in animals injected with Fc-ephrin-B2 (80.6% ± 0.87%) as compared to PBS 
(40.65% ± 4.15%), ephrin-B2 (50.3% ± 3.45%), and Anti-Fc (50.37% ± 9.28%) controls 
(Fig. 3b,d). These results indicate that ephrin-B2 signaling in vivo may regulate early stages 
of adult hippocampal neurogenesis by modulating NSC proliferation and/or differentiation, 
but further analysis is required to distinguish between these two possibilities.
Astroctyic ephrin-B2 regulates neurogenesis in vitro
Exogenous ephrin-B2 elevates hippocampal neurogenesis, and astrocytes expressing ephrin-
B2 contact NSCs in the hippocampus; however, it remains unclear whether astrocytic 
ephrin-B2 regulates NSC fate. Previous studies have shown that hippocampal astrocytes 
promote neuronal differentiation of co-cultured NSCs through secretion of soluble Wnt3a 
and by unidentified membrane-bound signaling molecules22,23.To determine whether 
ephrin-B2 is a key component of this membrane-associated activity, we first verified its 
expression in cultured hippocampal astrocytes. Consistent with the in vivo results (Fig. 1), 
QPCR revealed that hippocampus-derived astrocytes express ephrin-B2 mRNA at levels 
three orders of magnitude higher than cultured NSCs (Supplementary Fig. 2a). Notably, 
cultured NSCs down-regulate EphB4 and up-regulate ephrin-B2 expression upon astrocytic 
differentiation, yet maintain EphB4 expression on their soma upon neuronal differentiation 
into DCX+ immature neurons (Supplementary Fig. 2b).
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We then analyzed whether RNAi-mediated knockdown of ephrin-B2 in hippocampal 
astrocytes could compromise their ability to induce neuronal differentiation of NSCs in co-
culture. We screened five candidate anti-efnb2 shRNA sequences expressed under a human 
and/or a mouse U6 promoter upstream of a human ubiquitin-C promoter eGFP expression 
cassette (Supplementary Fig. 3). Upon lentiviral delivery, QPCR analysis indicated that two 
shRNA constructs (efnb2 shRNA #1 and #2) could knockdown ephrin-B2 mRNA levels in 
astrocytes by approximately 90 and 85%, respectively (Fig. 4a). Next, BrdU-labeled NSCs 
(<95%) were seeded on near-confluent layers of mitotically inactivate astrocytes, that were 
naïve or expressing efnb2 shRNA #1, #2, or LacZ shRNA, and the co-cultures were 
immunostained after six days. NSC proliferation was insignificant in all experimental 
groups. However, the percentage of βIII-Tubulin+/BrdU+ cells increased from 6.79 ± 0.62% 
in NSC-only control cultures to 14.2 ± 0.55% in NSC/ naïve astrocyte co-cultures (Fig. 4b), 
levels consistent with a prior NSC-astrocyte co-culture study22, and the neuronally 
differentiated NSCs were primarily located in close proximity to astrocytes (Fig. 4c). A 
similar proneuronal effect was maintained by astrocytes expressing the LacZ shRNA (15.4 ± 
1.12%); however, knockdown of ephrin-B2 expression within efnb2 shRNA #1 and #2 
astrocytes decreased their neuronal instructive potential by ~70%, i.e. to 9.09 ± 0.39% and 
9.51 ± 0.11% βIII-Tubulin+/BrdU+ cells, respectively. Intriguingly, this decrease in NSC 
neuronal differentiation due to ephrin-B2 knockdown is comparable to the previously 
observed ~55% loss when NSCs were cultured in astrocyte-conditioned medium rather than 
in co-culture22. Furthermore, antibody blockage of EphB4 receptors in the co-culture assay 
also significantly inhibited the proneuronal effect of naïve astrocytes, resulting in only 10.75 
± 0.87% of NSCs differentiating into βIII-Tubulin+/BrdU+ neurons. Ephrin-B2 is thus a key 
membrane-presented factor that hippocampal astrocytes employ to instruct neuronal 
differentiation of NSCs in vitro, and EphB4 receptors on NSCs transduce this signal.
Loss of astrocytic ephrin-B2 decreases neurogenesis in SGZ
To determine whether endogenous ephrin-B2 signaling promotes neuronal differentiation in 
vivo, adult rats were injected intrahippocampally with lentiviral vectors encoding efnb2 
shRNA #1, #2, or control LacZ shRNA. After two weeks, mitotic cells in the SGZ were 
labeled with BrdU, and tissue samples were collected after five additional days (Fig. 5a). 
Within GFP+ regions of the hippocampus, ephrin-B2 levels from rats treated with the efnb2 
shRNA constructs were dramatically lower than in sections from PBS or LacZ shRNA 
treated rats, which exhibited ephrin-B2 expression in patterns similar to GFAP staining (Fig. 
5b). We noted that neurons rather than astrocytes expressed GFP in the lentiviral vector-
infected hippocampi; however, it was later confirmed through administration of an 
otherwise identical lentiviral vector in which the human ubiquitin-C promoter was replaced 
with a GFAP promoter22 that the low GFP expression initially observed in astrocytes was 
due to the ubiquitin promoter (Supplementary Fig. 4a,b). In either case, the U6 promoter 
driving the shRNA expression mediated strong ephrin-B2 knockdown in hippocampal 
astrocytes (Fig. 5b and Supplementary Fig. 4c).
Next, BrdU+ and DCX+/BrdU+ cells in the SGZ were quantified within GFP+ hippocampi 
(Fig. 5c). In contrast to results obtained after administration of exogenous ephrin-B2, no 
significant difference in the number of BrdU+ cells/mm3 was observed in efnb2 shRNA #1 
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(33.2 ± 11.3%) and #2 (22.5 ± 2.50%) vs. LacZ shRNA control animals (29.0 ± 7.20%, Fig. 
5d), importantly indicating that endogenous ephrin-B2 signaling does not by itself regulate 
the proliferation of NSCs and Type 2b neuronal precursors. However, consistent with the 
proneuronal effect of Fc-ephrin-B2 in vitro and in vivo, the percentage of BrdU+ cells that 
co-stained for DCX was significantly lower in animals treated with efnb2 shRNA #1 (32.3 
±4.95%) and #2 (41.6 ± 3.41%) compared to LacZ shRNA (59.4 ± 2.33%, Fig. 5e). 
Therefore, knockdown of ephrin-B2 expression in hippocampal astrocytes decreased 
neurogenesis in the adult SGZ.
Ephrin-B2 signaling instructs NSC neuronal differentiation
To gain insight into whether neural stem and/or progenitor cell populations are modulated 
by ephrin-B2, we developed an inducible, conditional, reporter mouse strain to map the fate 
of Nestin+ NSCs in response to exogenous ephrin-B2. Nestin-CreERT2 35 and R26-stopfl/fl-
lacZ 36 mouse strains were bred to generate mice in which tamoxifen administration induces 
lacZ expression in Nestin+ cells via a transient recombination event. Using adult Nestin-
CreERT2; R26-stopfl/fl-lacZ mice, cells were co-labeled by BrdU and tamoxifen injections 
prior to an intrahippocampal injection of Fc-ephrin-B2 or the Anti-Fc antibody control, and 
tissue sections were collected at day 0 from sham mice and at day 5 and 14 post-treatment 
(Fig. 6a). Quiescent and mitotic cells in the SGZ were labeled β-Gal+ and BrdU+ in a near 
clonal fashion on day 0 (43.6 ± 7.95% of β-Gal+ cells were also BrdU+; 3.89 ± 1.00% of 
BrdU+ cells were also β-Gal+), and these cells expanded, differentiated, and migrated into 
the GCL over the 14-day observation period (Fig. 6b–h). At the population level, β-Gal+ 
hippocampal cells initially (day 0) consisted of Type 1 and 2a Nestin+/Sox2+ NSCs (90.7 ± 
1.79%), and a large fraction of β-Gal+ cells were specifically Type 1, radial, GFAP+/Sox2+ 
NSCs (53.8 ± 5.49%, Fig. 6b–f). By day 5, the total number of β-Gal+ cells had increased, 
but to the same extent in Fc-ephrin-B2 and Anti-Fc groups (Supplementary Fig. 5a). At this 
time point, however, a larger fraction of the β-Gal+ cell population in Fc-ephrin-B2 injected 
mice had shifted from Type 1 and 2a NSCs to neuronal fate committed Type 2b DCX+/
Sox2+ precursors and even more so to Type 3 DCX+/NeuroD1+ neuroblasts, as compared to 
Anti-Fc injected mice (Fig. 6d,e). By day 14, the total number of β-Gal+ cells was again 
consistent between experimental groups, but the increase in neuronal fated, β-Gal+ cells in 
Fc-ephrin-B2 versus Anti-Fc injected mice persisted as Type 2b and Type 3 cells matured 
into NeuN+ GCL neurons (Supplementary Fig. 5a and Fig. 6d–f).
To gain further insights into the early fate decisions that ephrin-B2 modulates,10 we 
analyzed individual β-gal+ cell clusters that are likely clonal. This quantification was 
conducted at day 5 in Nestin/Sox2 co-stained hippocampal sections (a total of 916 and 1145 
cell clusters analyzed in n=4 Anti-Fc control and n=5 Fc-ephrin-B2 treated brains, 
respectively). Type 1 (1) and Type 2a (2a) cells were identified by Nestin+/Sox2+ co-
staining and distinguished by morphology, and β-gal+/Nestin−/Sox2− cells were deemed 
astrocytes (A) or other neuronal cells (N, presumably neuronal precursors, neuroblasts, or 
mature neurons) by morphology and positioning relative to the GCL (Fig. 6i). We observed 
that the vast majority of clonal β-gal+ cell clusters contained 3 or fewer cells. Importantly 
the average number of cells per cluster was 1.55 ± 0.03 and 1.54 ± 0.04 cells in Anti-Fc and 
Fc-ephrin-B2 sections respectively, again indicating that Fc-ephrin-B2 did not enhance 
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proliferation of Type 1 or Type 2a cells, in contrast to the previously observed increase in 
BrdU+ cells with Fc-ephrin-B2 (Fig. 3c). Furthermore, the cell phenotype distribution of the 
β-gal+ cell clusters mirrored the overall, population-level results (Supplementary Fig. 5b and 
Fig. 6b–f). Specifically, the clearest result was that Fc-ephrin-B2 induced a significant 
decrease in the percentage of single Type 1 and single Type 2a cells and a corresponding 
increase in the number of single N cells (Fig. 6i). Likewise, there was a statistically 
significant decrease in the overall number of doublets containing a Type 1 cell (1 + X) or a 
Type 2a cell (2a + X), accompanied by an increase in the number of N + N doublets. These 
results are consistent with the interpretation that the ephrin-B2 induced the conversion of 
Type 1 and 2a cells toward more differentiated phenotypes, either with or without a cell 
division event. Finally, there was no significant change in the percentage of astrocyte-
containing clonal β-gal+ cell clusters, as anticipated due to the low levels of gliogenesis 
previously observed in this experimental paradigm (Supplementary Fig. 1). In summary, 
these results demonstrate that ephrin-B2 signaling significantly increases the commitment of 
Type 1 and Type 2a NSCs to a neuronal fate.
Wnt-independent induction of NSC neuronal differentiation
Activation of the canonical Wnt pathway elevates levels of β-catenin, followed by its 
nuclear translocation and association with Tcf/Lef transcription factors. Recently, this 
pathway was shown to regulate adult NSC differentiation by transcriptionally activating the 
proneural transcription factor NeuroD123,37. In zebrafish paraxial mesoderm, ephrin/Eph 
forward signaling recruits β-catenin to adherens junctions38, and EphB receptors are known 
transcriptional targets of β-catenin/Tcf signaling in stem cells in the mammalian gut39. 
However, to our knowledge, ephrin/Eph signaling has not previously been shown to activate 
β-catenin signaling. Notably, we found that Fc-ephrin-B2 stimulation progressively 
increased the levels of intracellular active β-catenin in cultured NSCs over a 24 hour period 
(Fig. 7a), initially detectable at 4 hours and rising to maximal levels by 24 hours. To 
determine whether this increased active β-catenin was mediated by EphB4, NSCs were pre-
incubated with anti-EphB4 antibody prior to Fc-ephrin-B2 addition. As observed in previous 
experiments (Fig. 2c,4b), EphB4 blockage decreased NSC responses to ephrin-B2 signaling 
and correspondingly limited the intracellular accumulation of active β-catenin (Fig. 7b).
In the canonical Wnt pathway, intracellular β-catenin levels are directly regulated by 
glycogen synthase kinase-3 beta (GSK3β), which phosphorylates and thereby marks β-
catenin for proteasomal degradation40. To determine whether elevated β-catenin activity is 
required for ephrin-B2’s proneuronal effect, we generated NSCs expressing a constitutively 
active form of GSK3β(GSK3β S9A)41. Upon stimulation with Fc-ephrin-B2, both naïve 
NSCs and NSCs carrying a control empty retroviral vector (CTL NSCs) exhibited increased 
levels of active β-catenin (Fig. 7c), consistent with prior results (Fig. 7a). However, 
GSK37S9A NSCs were unable to accumulate β-catenin in response to ephrin-B2 signaling. 
Furthermore, unlike naïve cells, GSK3 βS9A NSCs resisted neuronal differentiation when 
stimulated with Fc-ephrin-B2 or co-cultured with ephrin-B2 expressing naïve astrocytes, 
demonstrating that increased active β-catenin levels are required for ephrin-B2’s 
proneuronal effect (Fig. 7d,e).
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These results raise the possibility that ephrin-B2’s pro-neuronal effect could involve Wnt 
ligand mediated activation of β-catenin. To determine whether ephrin-B2 signaling 
indirectly activates β-catenin via upregulation of soluble Wnts in vivo, lentiviruses encoding 
a Tcf-Luc construct that reports β-catenin activity42 and either a dnWnt-IRES-GFP23 
(dominant negative Wnt) or IRES-GFP (control) cassette were used. We first confirmed that 
lentiviral mediated expression of the soluble dnWnt by cultured NSCs significantly 
decreased luciferase reporter expression upon incubation of the cells with Wnt3a 
(Supplementary Fig. 6). β-catenin reporter vector, as well as vector expressing dnWnt or 
GFP alone, was then co-administered in vivo. After two weeks, mitotic cells in the rat 
hippocampi were labeled with BrdU, and Fc-ephrin-B2 or PBS was administered by 
intrahippocampal injection. After 24 hours, in animals injected with Tcf-Luc and IRES-GFP 
constructs, Fc-ephrin-B2 increased the number of Luc+/BrdU+ cells, which also co-stained 
for active β-catenin (ABC) indicating that ephrin-B2 stimulates β-catenin signaling in vivo 
(Fig. 7f,g). Furthermore, administration of the dnWnt-IRES-GFP vector with the Tcf-Luc 
vector knocked down the number of Luc+/BrdU+ cells proportionally in the Fc-ephrin-B2 
and PBS injected groups, indicating that Wnt signaling is active in the hippocampus, but that 
ephrin-B2 still stimulates β-catenin signaling even when Wnt is inhibited. Consistent with 
these results, dnWnt reduced the number of newborn neurons in both the Fc-ephrin-B2 and 
PBS injected animals by day 5, but the former still showed a significantly higher number of 
DCX+/BrdU+ cells than the latter (Fig. 7g). Thus, ephin-B2 signaling does not apparently 
activate β-catenin through a soluble Wnt intermediate, and it can increase adult neurogenesis 
in the absence of Wnt signaling.
Finally, in NSC cultures stimulated with Fc-ephrin-B2, we observed a significant increase in 
the transcription of both Mash1 (Ascl1) and Neurod1, proneural transcription factors 
previously shown to play roles in adult hippocampal neurogenesis37,43 (Supplementary Fig. 
7a,b). This mRNA upregulation presumably occurs within the subset of cells that undergo 
neuronal differentiation. Therefore, our collective results strongly indicate that hippocampal 
astrocytes instruct neuronal differentiation of EphB4+ NSCs through juxtacrine ephrin-B2/
EphB4 forward signaling, which induces the expression of proneural transcription factors 
via a β-catenin-dependent and soluble Wnt independent mechanism.
Discussion
Stem cell niches present repertoires of signals that control cell maintenance, proliferation, 
and differentiation. Recent studies have identified several factors that regulate cell 
maintenance and proliferation within the adult NSC niche; however, few cues have been 
found to induce differentiation. Furthermore, whereas numerous soluble cues have been 
found to regulate adult neurogenesis, cell-cell interactions in the niche have in general been 
less studied. We have found that ephrin-B2 presented from hippocampal astrocytes activates 
β-catenin signaling in NSCs, upregulates the expression of key proneural transcription 
factors, and instructs their neuronal differentiation (Supplementary Fig. 8).
Hippocampal astrocytes, but not astrocytes derived from non-neurogenic regions of the 
central nervous system, regulate neurogenesis22, and a recent expression profiling analyzed 
the differential expression of factors that underlie this activity19. However, ephrin-B2 was 
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not represented on the Affymetrix chip used for this important comparative gene expression 
study, and cues dependent on cell-cell contact between the stem cells and hippocampal 
astrocytes have not been explored. The importance of ephrins and their receptors in axon 
guidance, neural tissue patterning, and synapse formation is well established24; however, 
less is known about their role in regulating adult NSCs. Several studies have shown that 
ephrin/Eph signaling can affect NSC proliferation31–33,44; however, these important studies 
did not address the potential for ephrins and Ephs to regulate stem cell differentiation within 
the brain. This work thus represents the first case of ephrin/Eph-family regulation of NSC 
neuronal lineage commitment in the adult CNS.
We have shown that endogenous ephrin-B2 is expressed by astrocytes in close proximity to 
adult NSCs, shRNA-mediated knockdown of the endogenous ephrin-B2 substantially lowers 
the fraction of newborn cells that become DCX+ neuronal precursors, and exogenous 
addition of ephrin-B2 induces the conversion of Type 1 and 2a NSCs toward Type 2b 
precursors and subsequently neurons (Fig. 2,5,6). Furthermore, lineage tracing analysis 
revealed a decrease in single Type 1 and Type 2a cells and an increase in the number of 
single neuroblasts and neurons in the presence of ephrin-B2, as well as a decrease in the 
number of cell doublets containing a Type 1 or 2a cell with a corresponding increase in the 
number of neuroblast and neuron doublets (Fig. 6). These results are consistent with ectopic 
ephrin-B2 inducing β-catenin signaling and upregulation of proneural transcription factors 
(Fig. 7 and Supplementary Fig.7a,b) to induce NSC differentiation independent of cell 
division. Collectively, our results indicate that juxtacrine signaling between astrocytes and 
NSCs provides a mechanism for the niche to locally control NSC differentiation. Prior 
results have investigated the importance of Notch and EphB2 signaling in modulating the 
properties of neighboring cells in the NSC niche45 and the importance of Notch in 
maintaining Type 1 NSCs13,46. Together, these results increasingly establish cell contact-
dependent signaling as a critical mechanism for locally regulating multiple stages in adult 
neurogenesis.
Ephrin/Eph signaling is generally known to be bidirectional, such that the Eph-presenting 
cell can activate signaling within the ephrin ligand-expressing cell24. We find that adult 
NSCs significantly upregulate ephrin-B2 and downregulate EphB4 expression upon 
differentiation into astrocytes in vitro, yet retain EphB4 expression upon neuronal 
differentiation (Supplementary Fig. 2b). Ephrin/Eph signal feedback from the differentiating 
NSC to neighboring cells could thus represent a mechanism to dynamically remodel the 
signaling environment of the niche, analogous to GDF11-dependent negative feedback from 
neurons to neural progenitors in the olfactory epithelium47 or EGF-dependent feedback from 
neural progenitors to neural stem cells in the SVZ48. In addition, ephrin and Eph expression 
dynamics could help control cell differentiation following NSC symmetric or asymmetric 
division8 and thereby contribute to maintaining or modulating the cellular composition of 
the niche. The potential of ephrin signaling in general to support self-renewing, asymmetric 
cell division – i.e. to generate a stem cell and a differentiated progeny – is virtually 
unexplored, as there is only one report of ephrin mediated regulation of asymmetric stem 
cell division, in the ascidian embryo49.
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Type 1 NSCs were depleted upon ephrin-B2 administration (Fig. 6), indicating that they 
may be direct targets of this ligand’s signaling. However, while some type 1 cells expressed 
levels of EphB4 detectable by immunostaining and upregulated β-catenin signaling upon 
ephrin-B2 addition, nearly all type 2a cells did so, and additional work will be needed to 
determine whether the observed differentiation of type 1 cells in response to ephrin-B2 is 
direct and/or indirect. In addition, while ephrin-B2 knockdown did not impact cell 
proliferation (Fig. 5d), and ephrin-B2 protein administration did not affect the proliferation 
of genetically-labeled, Nestin-expressing stem and progenitor cells (Fig. 6 and 
Supplementary Fig. 5), ephrin-B2 addition did result in the expansion of cells pre-labeled 
with BrdU in the rat brain. It is thus conceivable that in addition to its clear role in inducing 
the differentiation of NSCs at the expense of stem cell maintenance or self-renewing cell 
divisions (Fig. 6), ephrin-B2 could also modulate the expansion of later stage neuroblasts 
that are strongly labeled with BrdU, a possibility that could be explored in future work.
In summary, our findings reveal ephrin-B2, a transmembrane factor known for its role in 
cell and tissue patterning, as a key regulator of adult hippocampal neurogenesis, the first 
known function of an Eph-family protein in regulating neuronal lineage commitment of 
NSCs in the adult CNS. Additionally, hippocampal astrocytes are the source of the ephrin-
B2 signal, which further supports the emerging view that astroglia are active and essential 
regulators of an increasing number of adult CNS functions, including remodeling the 
neurogenic niche through local cellular interactions. Moreover, the discovery that ephrin-B2 
signals through β-catenin adds further understanding to the interconnected and likely 
synergistic nature by which niche factors regulate adult neurogenesis. Finally, this work may 
have future applications in modulating NSC function for treating brain injury and 
neurodegenerative disease.
Methods
Cell culture
NSCs isolated from the hippocampi of 6-week-old female Fisher 344 rats (Charles River), 
were cultured as previously described14 on poly-ornithine/laminin-coated plates in 
DMEM/F12 medium (Life Technologies) containing N2 supplement (Life Technologies) 
and 20 ng/mL FGF-2 (PeproTech), with subculturing upon reaching 80% confluency using 
Accutase (Phoenix Flow Systems). To induce differentiation, NSCs were cultured for five 
days in DMEM/F12/N2 medium supplemented with 2% fetal bovine serum (FBS, Life 
Technologies) and 1 µM retinoic acid (BIOMOL). Rat hippocampal astrocytes were isolated 
from Fisher 344 rats (Charles River) as previously described22 and cultured on poly-
ornithine/laminin-coated plates in DMEM/F12/N2 supplemented with 10% FBS, with 
subculture upon reaching 90% confluency using Trypsin EDTA (Mediatech, Inc.).
Fc-ephrin-B2 synthesis and differentiation assays
To generate Fc-ephrin-B2, mouse ephrin-B2/Fc (Sigma-Aldrich) was incubated at a 9:1 ratio 
(w/w) with a goat, anti-human IgG Fc antibody (Jackson ImmunoResearch USA) for 90 min 
at 4°C before immediate use. To differentiate NSC in vitro, eight-well chamber slides were 
seeded with 5×104 cells per well in standard culture medium containing 20 ng/mL FGF-2. 
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Next day, the medium was replaced with DMEM/F12 containing 0.5 ng/mL FGF-2 and 
various concentrations of Fc-ephrin-B2. Differentiation experiments were performed over a 
4 day period with a 50% media change daily. Then, the cells were fixed using 4% 
paraformaldehyde (PFA, Sigma Aldrich) and stained using standard protocols (see below). 
To test the effect of Eph receptor blocking, NSCs were pre-incubated with goat anti-EphB4 
or anti-EphB2 (1:50, Santa Cruz Biotechnology) for 30 minutes before addition of Fc-
ephrin-B2 ligands.
Lentiviral and retroviral vector construction
DNA cassettes containing either human or mouse U6 promoter driven expression of 
candidate shRNAs against rat efnb2 (Gene ID: 306636) were constructed by PCR. The 
forward primer containing a Pac I site for cloning and the reverse primer containing the 
entire shRNA sequence were used to amplify the U6 promoter from template plasmids 
pFhU6ABCgUGW (unpublished) or pmU6 pro. PCR was performed using Phusion high 
fidelity polymerase (Finnzymes) under the following conditions: pre-incubation at 98°C for 
2 min; 30 cycles, with 1 cycle consisting of 12 s at 98°C, 30 s at 55°C – 65°C, and 15 s – 25 
s at 72°C; and the final extension step of 2 min at 72°C. The U6 sense primers were 
sense_hU6 (5’-AACAATTAATTAAAAGGTCGGGCAGGAAGAGGGCCTATT-3’) and 
sense_mU6 (5’-AACAATTAATTAAATCCGACGCCGCCATCTCTAGGCC-3’). For a 
listing of the shRNA encoding antisense primers see Supplementary Table 1. In parallel, a 
control shRNA cassette against LacZ was constructed50 analogously, using pBS U6 shRNA 
β-gal as the template and with primers listed in Supplementary Table 1. All PCR products 
were digested with Pac I and cloned into the pFUGW lentiviral vector51 upstream of the 
human ubiquitin-C promoter and eGFP. pCLGPIT-GSK3 βS9A encoding a constitutively 
active form of GSK3 β (a gift of Ashley Fritz and Smita Agrawal) was constructed by 
amplifying the GSK3 βsequence from rat NSC cDNA, inserting it into pCLGPIT, and 
subjecting the plasmid to a site-directed mutagenesis to introduce the S9A mutation. 
Lentiviral and retroviral vectors were packaged using standard methods as described 
elsewhere52,53. Lastly, to validate functionality of the efnb2 shRNA vectors, the mouse 
GFAP promoter54 as well as the human GFAP promoter55 was cloned into the digested 
pFUGW vector, replacing the ubiquitin promoter upstream of eGFP.
Ephrin-B2 RNAi co-cultures
To select effective shRNA sequences targeting efnb2, hippocampus-derived astrocytes were 
transduced with lentivirus encoding trial shRNA sequences at an MOI of 3 and cultured for 
four days. RNA isolated from astrocyte cultures was analyzed for efnb2 expression using 
QPCR (see below and Supplementary Figure 3). For co-culture assays, hippocampus-
derived astrocytes were transduced with lentivirus encoding shRNA sequences at an MOI of 
3 and cultured for two days prior to a 3 day incubation in medium containing 20 µM 
cytosine arabinoside (AraC, Sigma-Aldrich) to deplete rapidly dividing astrocytes. Then, 
cells were returned to standard medium for 24 hours, before being subcultured onto 8-well 
chamber slides at a density of 70,000 cells/cm2. NSCs were transduced with retrovirus 
encoding either pCLGPIT or pCLGPIT-GSK3 βS9A at an MOI of 1 and cultured for two 
days before a 96-hour selection period in medium containing 1 µg/mL puromycin (Sigma-
Aldrich). Next, NSCs were incubated in standard media containing 25 µM 
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bromodeoxyuridine (BrdU, Sigma-Aldrich) for 48-hours. Then, the BrdU-labeled NSCs 
were seeded on top of a monolayer of astrocytes in 8-well chamber slides at a density of 
70,000 cells/cm2 in medium lacking FGF-2. Co-cultures were maintained for six days prior 
to fixation and analysis by immunocytochemistry.
In vivo gain and loss of function studies
All animal protocols were approved by the Institutional Animal Care and Use Committee of 
the University of California Berkeley. Eight-week-old adult female Fisher 344 rats received 
daily 50 mg/kg intraperitoneal (i.p.) injections of BrdU (Sigma Aldrich) dissolved in saline 
to label mitotic cells, as previously described14. In Fc-ephrin-B2 studies, animals were 
anesthetized prior to 3 µL bilateral intrahippocampal stereotaxic injections of either PBS 
(Life Technologies), ephrin-B2 (14 µg/mL), Anti-Fc antibody (126 µg/mL), or Fc-ephrin-B2 
(140 µg/mL) in PBS. The injection coordinates were −3.5 mm anteriorposterior and ± 2.5 
mm mediolateral relative to bregma, and −3.0 mm dorsoventral relative to dura. Refer to 
Figure 3a for injection time course. Unbiased stereology (Zeiss Axio Imager, software by 
MicroBrightfield) using the optical fractionator method was performed on eight, evenly 
distributed sections from each rat to estimate the total number of relevant cells throughout 
the entire hippocampus. In RNAi studies, rats received bilateral intrahippocampal injections 
of 3 µL of lentiviral solutions in PBS on day −19. The injection coordinates with respect to 
bregma were −3.5 mm anteriorposterior, −3.5 mm dorsoventral (i.e. from the dura), and ± 
2.0 mm mediolateral. Refer to Figure 5a for injection time course. Unbiased stereology was 
performed on eight GFP+ hippocampal sections from each rat, and the number of selected 
cells was normalized by the volume of hippocampal tissue analyzed.
In vivo fate mapping
Nestin-CreERT2 mice35 (a kind gift from Amelia Eisch, UT Southwestern, Dallas, TX) and 
R26-stopfl/fl-lacZ mice36 (a kind gift from John Ngai, UC Berkeley, Berkeley, CA), both 
having a 100% C57/Bl6 background, were crossbreed twice to generate a homozygous 
Nestin-CreERT2;R26-stopfl/fl-lacZ mosue strain. Geneotyping was performed using the 
following primers: Cre-F (5'-ACCAGCCAGCTATCAACTCG-3'), Cre-R (5'- 
TTACATTGGTCCAGCCACC-3'), 200bp; LacZ-F (5'-
GTCAATCCGCCGTTTGTTCCCACG-3'), LacZ-R (5'-
CCAGTACAGCGCGGCTGAAATCAT-3'), 400 bp; wtRosa-F (5'-
GGAGCGGGAGAAATGGATATG-3'), wtRosa-R (5'- 
AAAGTCGCTCTGAGTTGTTAT-3'), 600bp. To induce recombination and label mitotic 
cells, 5 week old Nestin-CreERT2;R26-stopfl/fl-lacZ mice were administered i.p. 180 mg/kg 
tamoxifen (SigmaAldrich) dissolved in corn oil and 50 mg/kg BrdU daily for three days 
prior to intrahippocampal injections of experimental solutions. 1 µL of Anti-Fc (126 µg/mL) 
and Fc-ephrin-B2 (140 µg/mL) in PBS were then administered at −2.12 mm 
anteriorposterior, −1.55 mm dorsoventral (from dura), and ± 1.5 mm mediolateral with 
respect to the bregma. Pre-determined groups of mice (balanced in male-to-female ratio) 
were sacrificed at Day 0 (Sham), 5, and 14 time points, and tissue collection and histology 
were performed.
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In vitro validation of β-catenin reporter and dnWnt vectors
NSCs were co-infected with 7xTcf-FFluc42 (Tcf-Luc) and either LV-dnWnt-IRES-GFP23 or 
LV-GFP and expanded in culture. After a 24-hour pulse with Wnt3a (200 ng/mL), cell 
lysates were collected and analyzed using Luc-Screen® Extended-Glow Luciferase Reporter 
Gene Assay System (Applied Biosystems) and a TD-20/20 luminometer (Turner 
BioSystems) to determine the relative level of β-catenin activation.
In vivo β-catenin activation and Wnt-independent neurogenesis
Eight-week-old adult female Fisher 344 rats received bilateral, intrahippocampal, stereotaxic 
injections of 3 µL of a mixture of half 7xTcf-FFluc42 (Tcf-Luc) and half LV-dnWnt-IRES-
GFP23 or LV-GFP (kind gifts from Fred Gage, Salk Institute, La Jolla, CA) lentiviral 
vectors on Day −17. Starting on Day −3, animals were intraperitoneally injected with BrdU 
(50 mg/kg) for three days prior to subsequent bilateral intrahippocampal stereotaxic 
injections of 3 uL of either Fc-ephrin-B2 (140 µg/mL) or PBS on Day 0. The injection 
coordinates with respect to the bregma were −3.5 mm anteriorposterior, −3.4 mm 
dorsoventral (from dura), and ± 1.8 mm mediolateral. Animals were sacrificed on Day 1 and 
half were sacrificed on Day 5 before brains were processed for histology and analyzed by 
stereology.
Immunostaining and imaging
Cells cultures were fixed with 4% paraformaldehyde (PFA) for 10 minutes, blocked for 1 
hour with 5% donkey serum (Sigma), permeabilized with 0.3% Triton X-100 (Calbiochem), 
and incubated for 48 hours with combinations of the following primary antibodies: mouse 
anti-nestin (1:1000, BD Pharmingen), rabbit anti-GFAP (1:250, Abcam), rabbit anti- βIII-
Tubulin (1:250, Sigma), and rabbit anti-MBP (1:500, Santa Cruz). Appropriate Cy3-, Cy5-, 
or Alexa Fluor 488-conjugated secondary antibodies were used to detect primary antibodies 
(1:250, Jackson Immunoresearch; 1:250, Molecular Probes). TO-PRO-3 (10 µM, Life 
Technologies) or DAPI was used as the nuclear counterstain.
Animals were perfused with 4% PFA (Sigma), and brain tissue was extracted, stored in 
fixative for 24 hours, and allowed to settle in a 30% sucrose solution. Brains were coronally 
sectioned and immunostained using previously published protocols14. Primary antibodies 
used were mouse anti-BrdU (1:100, Roche), mouse anti-NeuN (1:100, Millipore), rat anti-
BrdU (1:100, Abcam), goat anti-doublecortin (1:50, Santa Cruz Biotechnology), rabbit anti-
GFAP (1:1000, Abcam), guinea pig anti-doublecortin (1:1000, Millipore), goat anti-ephrin-
B2 (1:10, R&D Systems), rabbit anti-Sox2 (1:250, Millipore), goat anti-EphB4 (1:50, Santa 
Cruz), mouse anti-GFAP (1:2000, Advanced Immunochemical), rabbit anti-GFP (1:2000, 
Life Technologies), goat anti-GFP (1:200, Abcam), and rabbit anti- β-Gal (Gift from John 
Ngai). Appropriate Cy3-, Cy5-, or Alexa Fluor 488-conjugated secondary antibodies (1:125, 
Jackson Immunoresearch; 1:250, Life Technologies) were used. For sections stained with rat 
anti-BrdU, biotin-conjugated anti-rat IgG (1:250, Jackson Immunoresearch) was used as the 
secondary, which was then washed and incubated with Cy3-conjugated streptavidin (1:1000, 
Jackson Immunoresearch USA) for 2 hours to amplify the signal. DAPI (50 µg/mL, 
Invitrogen) was used as a nuclear counterstain. Sections were mounted on glass slides and 
analyzed using the optical fractionator method in unbiased stereological microscopy (Zeiss 
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Axio Imager, software by MicroBrightfield) and/or imaged with either a Leica 
Microsystems confocal microscope or a Zeiss 510 Meta UV/VIS confocal microscope 
located in the CNR Biological Imagining Facility at the University of California Berkeley.
Western blotting
NSCs were seeded at 2.5×105 cells per well in a 6-well culture dish in standard culture 
medium containing 0.1 µg/mL FGF2. The following day, 10 µg/mL Fc-ephrin-B2 was added 
using a 50% media change. To test the effect of inhibition of the EphB4 receptor, NSCs 
were pre-incubated with goat anti-EphB4 (1:50, Santa Cruz Biotechnology) for 30 minutes 
before addition of Fc-ephrin-B2. Cell lysates were collected at various time intervals (0–24 
hours after Fc-ephrin-B2 addition) and Western blotted as previously described56. On 
nitrocellulose membranes, proteins were labeled using anti-active β-catenin (1:500, 
Millipore) and rabbit anti-total GSK-3 β(1:1000, Cell Signaling) primary antibodies in 
combination with the appropriate HRP-conjugated secondary antibody (1:10,000, Pierce). 
SuperSignal West Dura Extended Duration Substrate (Pierce) was used to detect the protein 
bands, and after film development (Kodak Film Processor 5000RA), membranes were 
stripped and re-probed with rabbit anti-GAPDH (1:2500, Abcam).
RNA isolation and QPCR
RNA samples were isolated using standard Trizol (Life Technologies) collection and ethanol 
precipitation. RNA samples were quantified using a NanoDrop Spectrophotomer ND-1000 
(NanoDrop Technologies, Inc.), and equivalent amounts of RNA were added to QPCR 
reactions. Quantitative PCR was performed to probe for expression of nestin, GFAP, β-
Tubulin III, and 18S mRNA using prior protocols57. For analysis of ephrin-B2 mRNA 
levels, QPCR was performed using a Taqman Gene Expression Assay (Applied Biosystems) 
for efnb2 (#Rn01215895_m1) and for eukaryotic 18S (#803026). All reactions were 
performed using a BioRad IQ™5 Multicolor Real-Time Detection System, and target 
mRNA expression levels were normalized according to levels of 18S.
Statistical analysis
Statistical significance of the results was determined using an ANOVA and multiple means 
comparison function (i.e. Tukey-Kramer Analysis) in MATLAB. Data are represented as 
means ± s.d.
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Refer to Web version on PubMed Central for supplementary material.
Acknowledgements
This research was supported by NIH grant EB007295, LBL LDRD grant 3668DS, and CIRM training grant 
T1-00007. We also thank Russell Fletcher for his guidance in mouse breeding and geneotyping.
References
1. Eriksson PS, et al. Neurogenesis in the adult human hippocampus. Nat. Med. 1998; 4:1313–1317. 
[PubMed: 9809557] 
Ashton et al. Page 14
Nat Neurosci. Author manuscript; available in PMC 2013 April 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
2. Lois C, Alvarez-Buylla A. Long-distance neuronal migration in the adult mammalian brain. Science. 
1994; 264:1145–1148. [PubMed: 8178174] 
3. Spalding KL, Bhardwaj RD, Buchholz BA, Druid H, Frisén J. Retrospective birth dating of cells in 
humans. Cell. 2005; 122:133–143. [PubMed: 16009139] 
4. Manganas LN, et al. Magnetic resonance spectroscopy identifies neural progenitor cells in the live 
human brain. Science. 2007; 318:980–985. [PubMed: 17991865] 
5. Jessberger S, et al. Seizure-associated, aberrant neurogenesis in adult rats characterized with 
retrovirus-mediated cell labeling. J. Neurosci. 2007; 27:9400–9407. [PubMed: 17728453] 
6. Ekdahl CT, Claasen JH, Bonde S, Kokaia Z, Lindvall O. Inflammation is detrimental for 
neurogenesis in adult brain. Proc. Natl. Acad. Sci. U.S.A. 2003; 100:13632–13637. [PubMed: 
14581618] 
7. Tattersfield AS, et al. Neurogenesis in the striatum of the quinolinic acid lesion model of 
Huntington's disease. Neuroscience. 2004; 127:319–332. [PubMed: 15262322] 
8. Suh H, et al. In vivo fate analysis reveals the multipotent and self-renewal capacities of Sox2+ 
neural stem cells in the adult hippocampus. Cell Stem Cell. 2007; 1:515–528. [PubMed: 18371391] 
9. Suh H, Deng W, Gage FH. Signaling in adult neurogenesis. Annu. Rev. Cell Dev. Biol. 2009; 
25:253–275. [PubMed: 19575663] 
10. Bonaguidi MA, et al. In Vivo Clonal Analysis Reveals Self-Renewing and Multipotent Adult 
Neural Stem Cell Characteristics. Cell. 2011; 145:1142–1155. [PubMed: 21664664] 
11. Mira H, et al. Signaling through BMPR-IA Regulates Quiescence and Long-Term Activity of 
Neural Stem Cells in the Adult Hippocampus. Cell Stem Cell. 2010; 7:78–89. [PubMed: 
20621052] 
12. Ehm O, et al. RBPJ -Dependent Signaling Is Essential for Long-Term Maintenance of Neural Stem 
Cells in the Adult Hippocampus. J. Neurosci. 2010; 30:13794–13807. [PubMed: 20943920] 
13. Lugert S, et al. Quiescent and active hippocampal neural stem cells with distinct morphologies 
respond selectively to physiological and pathological stimuli and aging. Cell Stem Cell. 2010; 
6:445–456. [PubMed: 20452319] 
14. Lai K, Kaspar BK, Gage FH, Schaffer DV. Sonic hedgehog regulates adult neural progenitor 
proliferation in vitro and in vivo. Nat. Neurosci. 2003; 6:21–27. [PubMed: 12469128] 
15. Jin K, et al. Neurogenesis and aging: FGF-2 and HB-EGF restore neurogenesis in hippocampus 
and subventricular zone of aged mice. Aging Cell. 2003; 2:175–183. [PubMed: 12882410] 
16. Cao L, et al. VEGF links hippocampal activity with neurogenesis, learning and memory. Nat. 
Genet. 2004; 36:827–835. [PubMed: 15258583] 
17. Qu Q, et al. Orphan nuclear receptor TLX activates Wnt/beta-catenin signalling to stimulate neural 
stem cell proliferation and self-renewal. Nat. Cell Biol. 2010; 12:31–40. sup pp 1–9. [PubMed: 
20010817] 
18. Gage FH, et al. Survival and differentiation of adult neuronal progenitor cells transplanted to the 
adult brain. Proc. Natl. Acad. Sci. U.S.A. 1995; 92:11879–11883. [PubMed: 8524867] 
19. Barkho BZ, et al. Identification of astrocyte-expressed factors that modulate neural stem/progenitor 
cell differentiation. Stem Cells Dev. 2006; 15:407–421. [PubMed: 16846377] 
20. Tozuka Y, Fukuda S, Namba T, Seki T, Hisatsune T. GABAergic excitation promotes neuronal 
differentiation in adult hippocampal progenitor cells. Neuron. 2005; 47:803–815. [PubMed: 
16157276] 
21. Jacobs S, et al. Retinoic acid is required early during adult neurogenesis in the dentate gyrus. Proc. 
Natl. Acad. Sci. U.S.A. 2006; 103:3902–3907. [PubMed: 16505366] 
22. Song H, Stevens CF, Gage FH. Astroglia induce neurogenesis from adult neural stem cells. Nature. 
2002; 417:39–44. [PubMed: 11986659] 
23. Lie DC, et al. Wnt signalling regulates adult hippocampal neurogenesis. Nature. 2005; 437:1370–
1375. [PubMed: 16251967] 
24. Pasquale EB. Eph receptor signalling casts a wide net on cell behaviour. Nat. Rev. Mol. Cell Biol. 
2005; 6:462–475. [PubMed: 15928710] 
25. Knöll B, Drescher U. Ephrin-As as receptors in topographic projections. Trends Neurosci. 2002; 
25:145–149. [PubMed: 11852146] 
Ashton et al. Page 15
Nat Neurosci. Author manuscript; available in PMC 2013 April 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
26. Martínez A, Soriano E. Functions of ephrin/Eph interactions in the development of the nervous 
system: emphasis on the hippocampal system. Brain Res. Brain Res. Rev. 2005; 49:211–226. 
[PubMed: 16111551] 
27. Xu NJ, Sun S, Gibson JR, Henkemeyer M. A dual shaping mechanism for postsynaptic ephrin-B3 
as a receptor that sculpts dendrites and synapses. Nat. Neurosci. 2011; 14:1421–1429. [PubMed: 
21964490] 
28. Aoki M, Yamashita T, Tohyama M. EphA receptors direct the differentiation of mammalian neural 
precursor cells through a mitogen-activated protein kinase-dependent pathway. J. Biol. Chem. 
2004; 279:32643–32650. [PubMed: 15145949] 
29. del Valle K, Theus MH, Bethea JR, Liebl DJ, Ricard J. Neural progenitors proliferation is inhibited 
by EphB3 in the developing subventricular zone. Int. J. Dev. Neurosci. 2011; 29:9–14. [PubMed: 
20969945] 
30. Conover JC, et al. Disruption of Eph/ephrin signaling affects migration and proliferation in the 
adult subventricular zone. Nat. Neurosci. 2000; 3:1091–1097. [PubMed: 11036265] 
31. Holmberg J, et al. Ephrin-A2 reverse signaling negatively regulates neural progenitor proliferation 
and neurogenesis. Gene Dev. 2005; 19:462–471. [PubMed: 15713841] 
32. Chumley MJ, Catchpole T, Silvany RE, Kernie SG, Henkemeyer M. EphB receptors regulate stem/
progenitor cell proliferation, migration, and polarity during hippocampal neurogenesis. J. 
Neurosci. 2007; 27:13481–13490. [PubMed: 18057206] 
33. Hara Y, Nomura T, Yoshizaki K, Frisén J, Osumi N. Impaired hippocampal neurogenesis and 
vascular formation in ephrin-A5-deficient mice. Stem Cells. 2010; 28:974–983. [PubMed: 
20474079] 
34. Davis S, et al. Ligands for EPH-related receptor tyrosine kinases that require membrane attachment 
or clustering for activity. Science. 1994; 266:816–819. [PubMed: 7973638] 
35. Battiste J, et al. Ascl1 defines sequentially generated lineage-restricted neuronal and 
oligodendrocyte precursor cells in the spinal cord. Development. 2007; 134:285–293. [PubMed: 
17166924] 
36. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 1999; 
21:70–71. [PubMed: 9916792] 
37. Kuwabara T, et al. Wnt-mediated activation of NeuroD1 and retro-elements during adult 
neurogenesis. Nat. Neurosci. 2009; 12:1097–1105. [PubMed: 19701198] 
38. Barrios A, et al. Eph/Ephrin signaling regulates the mesenchymal-to-epithelial transition of the 
paraxial mesoderm during somite morphogenesis. Curr. Biol. 2003; 13:1571–1582. [PubMed: 
13678588] 
39. Batlle E, et al. Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by 
controlling the expression of EphB/ephrinB. Cell. 2002; 111:251–263. [PubMed: 12408869] 
40. Kim WY, et al. GSK-3 is a master regulator of neural progenitor homeostasis. Nat. Neurosci. 2009; 
12:1390–1397. [PubMed: 19801986] 
41. Stambolic V, Woodgett JR. Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells 
via serine 9 phosphorylation. Biochem. J. 1994; 303(Pt 3):701–704. [PubMed: 7980435] 
42. Fuerer C, Nusse R. Lentiviral vectors to probe and manipulate the Wnt signaling pathway. PLoS 
ONE. 2010; 5:e9370. [PubMed: 20186325] 
43. Elmi M, et al. TLX activates MASH1 for induction of neuronal lineage commitment of adult 
hippocampal neuroprogenitors. Mol. Cell. Neurosci. 2010; 45:121–131. [PubMed: 20599619] 
44. Jiao JW, Feldheim DA, Chen DF. Ephrins as negative regulators of adult neurogenesis in diverse 
regions of the central nervous system. Proc. Natl. Acad. Sci. U.S.A. 2008; 105:8778–8783. 
[PubMed: 18562299] 
45. Nomura T, Göritz C, Catchpole T, Henkemeyer M, Frisén J. EphB signaling controls lineage 
plasticity of adult neural stem cell niche cells. Cell Stem Cell. 2010; 7:730–743. [PubMed: 
21112567] 
46. Ables JL, et al. Notch1 is required for maintenance of the reservoir of adult hippocampal stem 
cells. J. Neurosci. 2010; 30:10484–10492. [PubMed: 20685991] 
47. Wu HH, et al. Autoregulation of neurogenesis by GDF11. Neuron. 2003; 37:197–207. [PubMed: 
12546816] 
Ashton et al. Page 16
Nat Neurosci. Author manuscript; available in PMC 2013 April 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
48. Aguirre A, Rubio ME, Gallo V. Notch and EGFR pathway interaction regulates neural stem cell 
number and self-renewal. Nature. 2010; 467:323–327. [PubMed: 20844536] 
49. Picco V, Hudson C, Yasuo H. Ephrin-Eph signalling drives the asymmetric division of notochord/
neural precursors in Ciona embryos. Development. 2007; 134:1491–1497. [PubMed: 17344225] 
50. Qin XF, An DS, Chen ISY, Baltimore D. Inhibiting HIV-1 infection in human T cells by lentiviral-
mediated delivery of small interfering RNA against CCR5. Proc. Natl. Acad. Sci. U.S.A. 2003; 
100:183. [PubMed: 12518064] 
51. Lois C, Hong EJ, Pease S, Brown EJ, Baltimore D. Germline transmission and tissue-specific 
expression of transgenes delivered by lentiviral vectors. Science. 2002; 295:868–872. [PubMed: 
11786607] 
52. Yu JH, Schaffer DV. Selection of novel vesicular stomatitis virus glycoprotein variants from a 
peptide insertion library for enhanced purification of retroviral and lentiviral vectors. J. Virol. 
2006; 80:3285–3292. [PubMed: 16537595] 
53. Lim KI, Klimczak R, Yu JH, Schaffer DV. Specific insertions of zinc finger domains into Gag-Pol 
yield engineered retroviral vectors with selective integration properties. Proc. Natl. Acad. Sci. 
U.S.A. 2010; 107:12475–12480. [PubMed: 20616052] 
54. Greenberg KP, Geller SF, Schaffer DV, Flannery JG. Targeted transgene expression in muller glia 
of normal and diseased retinas using lentiviral vectors. Invest. Ophthalmol. Vis. Sci. 2007; 
48:1844–1852. [PubMed: 17389520] 
55. Lawlor PA, Bland RJ, Mouravlev A, Young D, During MJ. Efficient gene delivery and selective 
transduction of glial cells in the mammalian brain by AAV serotypes isolated from nonhuman 
primates. Mol. Ther. 2009; 17:1692–1702. [PubMed: 19638961] 
56. Peltier J, O'Neill A, Schaffer DV. PI3K/Akt and CREB regulate adult neural hippocampal 
progenitor proliferation and differentiation. Dev Neurobiol. 2007; 67:1348–1361. [PubMed: 
17638387] 
57. Peltier J, Agrawal S, Robertson MJ, Schaffer DV. In vitro culture and analysis of adult 
hippocampal neural progenitors. Methods Mol. Biol. 2010; 621:65–87. [PubMed: 20405360] 
Ashton et al. Page 17
Nat Neurosci. Author manuscript; available in PMC 2013 April 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 1. 
In vivo, SGZ Type 2a NSCs, Type 2b neuronal precursors, and Type 3 neuroblasts express 
EphB4, and hippocampal astrocytes express ephrin-B2. (a) Staining of the hippocampal 
dentate gyrus showed that GFAP+ hilar (H) astrocytes express ephrin-B2. In addition, cells 
in the SGZ and neurons in the granule cell layer (GCL) express EphB4+ on the cell soma. 
Scale bar represents 100 µm. (b) GFAP+ astrocytes adjacent to the SGZ co-express ephrin-
B2. (c,d) EphB4 expression persists throughout NSC neuronal differentiation, including 
Type 2a NSCs (Sox2+/DCX−/GFAP−), Type 2b neuronal precursors (Sox2+/DCX+), and 
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Type 3 neuroblasts (DCX+). (c) Confocal images show EphB4 expression in Sox2+/DCX− 
cells (large arrowheads) in the SGZ. Magnified region depicts the presence of EphB4 
expression on a Sox2+/DCX+ Type 2b neuronal precursor (small arrowhead) and a DCX+ 
Type 3 neuroblast (arrow). (d) Confocal images also show EphB4 expression by Sox2+/
GFAP− cells (small arrowheads); therefore, Sox2+/DCX−/GFAP− Type 2a NSCs also 
express EphB4. (e) Given the close proximity of ephrin-B2+ astrocytes to EphB4+ cells in 
the SGZ, ephrin-B2/EphB4 juxtacrine signaling is in a position to induce NSC 
differentiation into (f) Sox2+/DCX+ Type 2b neuronal precursors (small arrowhead) and 
subsequently Sox2−/DCX+ Type 3 neuroblasts (arrow). The scale bars represent 10 µm.
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Figure 2. 
Fc-ephrin-B2 promoted the neuronal differentiation of NSCs in vitro. (a,b) Stimulation by 
Fc-Ephrin-B2 induced NSCs to undergo neuronal differentiation (βIII-Tubulin+ or Tubb3) in 
a dose-responsive fashion as measured by immunocytochemistry and QPCR (n = 3, 
experimental replicates). Glial fibrilary acidic protein (GFAP) staining was slightly 
increased with ephrin-B2, but no increase in expression was observed by QPCR. (c) 
Blockage of ephrin-B2 receptors, EphB2 and EphB4, during Fc-ephrin-B2 (10 µg/mL) 
stimulation revealed that EphB4 mediates Fc-ephrin-B2’s proneuronal effect on NSCs (n = 
3, experimental replicates). ANOVA plus a multi-variable Tukey-Kramer analysis was 
conducted, with * indicating P <0.01 and ** indicating P <0.05. Data are represented as 
means ± s.d. (d) Nestin+/Sox2+ NSCs express EphB4 as demonstrated by 
immunocytochemistry and RT-PCR. Scale bar represents 100 µm.
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Figure 3. 
Intrahippocampal injection of Fc-ephrin-B2 increases neurogenesis in the SGZ. (a) 
Schematic of experimental time course. (b) Administration of Fc-ephrin-B2 into the 
hippocampus significantly increased neurogenesis as shown by representative confocal 
images of the dentate gyrus and SGZ (close-up). The scale bar represents 100 µm. (c) The 
injection of exogenous ephrin-B2 ligands increased BrdU+ cell numbers compared to 
vehicle and constituent controls. (d) Only injection of Fc-ephrin-B2, but not its constituent 
controls, increased the percentage of BrdU+ cells that co-stained for DCX in the SGZ (n = 3 
brains, analyzed 8 hippocampal sections per brain). * indicates P <0.01, and ** indicates P 
<0.05; ± s.d.
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Figure 4. 
Ephrin-B2 RNAi decreases the proneuronal effect of hippocampus-derived astrocytes in 
vitro. (a) Efnb2 shRNA lentiviral vectors (#1 and #2) significantly inhibit efnb2 expression 
in hippocampus-derived astrocytes. Expression levels were measured by QPCR and 
normalized to efnb2 expression in non-infected hippocampus-derived astrocytes (i.e. 100%). 
Also, hippocampus-derived astrocytes express orders of magnitude more efnb2 than NSCs 
(n = 3, technical replicates). (b) Naïve astrocytes and astrocytes expressing a control LacZ 
shRNA promoted neuronal differentiation of NSCs, compared to NSC-only cultures. 
However, knockdown of astrocyte efnb2 expression, or antibody blockage of NSC EphB4 
receptors, significantly diminished the proneuronal effect of hippocampus-derived 
astrocytes, as demonstrated by the decrease in the percentage of βIII-Tubulin+/ BrdU+ NSCs 
to levels closer to those in NSC-only cultures (n = 4, experimental replicates). The solid 
black line indicates the level of βIII-Tubulin+/BrdU+ cells at the start of the experiment. (c) 
Representative confocal image of BrdU-labeled NSCs differentiated into βIII-Tubulin+ 
neurons after co-culture with lentiviral vector-expressing, i.e. GFP+, astrocytes. NSCs 
adjacent to astrocytes had a higher propensity for neuronal differentiation. Scale bar 
represents 100 µm. * indicates P <0.01; ± s.d.
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Figure 5. 
Ephrin-B2 RNAi decreases neuronal differentiation of BrdU+ cells in the SGZ. (a) 
Schematic of experimental time course. (b) Regions of the hippocampus transduced with 
lentiviral vector (GFP+) carrying efnb2 shRNA #1 and #2 (data not shown) showed 
considerably less ephrin-B2 staining than hippocampi transduced with LacZ shRNA 
lentivirus injected rats. (c) Representative confocal images showing decreased neuronal 
differentiation, i.e. DCX+ co-staining, of BrdU+ (arrowheads) cells in the SGZ of rats 
injected with lentivirus encoding efnb2 shRNA. Scale bars represent 100 µm. (d,e) 
Ashton et al. Page 23
Nat Neurosci. Author manuscript; available in PMC 2013 April 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Knockdown of ephrin-B2 in the hippocampal niche did not affect BrdU+ cell numbers, but it 
did result in a significant decrease in the percentage of BrdU+ cells that co-stained for DCX 
in the SGZ (n = 4 brains, analyzed 8 hippocampal sections per brain). This suggests that 
endogenous ephrin-B2 signaling regulates neuronal differentiation of NSCs. * indicates 
p<0.01; ± s.d; dotted line marks SGZ/Hilus boundary and dashed line marks GCL/MCL 
boundary.
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Figure 6. 
Lineage tracing of ephrin-B2-induced NSC differentiation. (a) Time course where (b,c) 
initially 90.7 ± 1.79% of β-Gal+ cells were Nestin+/Sox2+, and 53.8 ± 5.49% were GFAP+ 
along radial process (Type 1 NSCs). (d,e) By day 5, 38.7 ± 2.73% and 37.3 ± 4.51% of β-
Gal+ cells were Sox2+/DCX+ and DCX+/NeuroD1+, respectively, in Fc-ephrin-B2 injected 
mice vs. 27.7 ± 5.16% and 13.8 ± 4.38% in Anti-Fc controls. (f) At day 14, 41.1 ± 4.86% of 
β-Gal+ cells were NeuN+ for Fc-ephrin-B2 vs. 25.6 ± 4.24% for controls. (g,h) 
Representative sections where β-Gal+ and BrdU+ cells proliferated and differentiated over 
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14 days. (i) Compared to Anti-Fc, Fc-ephrin-B2 decreased the number of single Type 1 (“1”, 
8.01 ± 1.91% vs. 17.8 ± 1.93%) and Type 2a NSCs (“2a”, 2.51 ± 2.34% vs. 10.8 ± 3.22%) 
and increased single neuroblast or neurons (“N”, 49.2 ± 4.57% vs. 30.9 ± 2.28%). 
Furthermore, ephrin-B2 decreased the number of doublets containing a Type 1 (“1+X”, 5.95 
± 1.47% vs. 11.8 ± 2.03%) or Type 2 (“2a+X”, 7.37 ± 3.00% vs. 16.5 ± 6.03%) cell and 
increased neuroblasts or neuron doublets (“N+N”,16.3 ± 1.82% vs. 3.87 ± 1.65%). Cluster 
size (1.55 ± 0.03 vs. 1.54 ± 0.04) and overall β-Gal+ cell numbers (Supplementary Fig. 5) 
were indistinguishable in Fc-ephrin-B2 vs. control mice. Thus, ephrin-B2 signaling 
increases neuronal differentiation without altering proliferation. ** P <0.05; ± s.d; Five 
sections (10 hemispheres) analyzed in n = 4 Anti-Fc and 5 Fc-ephrin-B2 brains; dotted vs. 
dashed lines mark SGZ/Hilus vs. GCL/MCL boundaries.
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Figure 7. 
Ephrin-B2 instructs neuronal differentiation by activating β-catenin independent of Wnt 
signaling. (a) Fc-ephrin-B2 (10 µg/mL) induced active β-catenin accumulation in NSCs over 
a 24 hours. (b) However, blocking the EphB4 receptor compromised Fc-ephrin-B2 induction 
of β-catenin accumulation. (c) NSCs expressing a constitutively active GSK3 β, GSK3 
ββS9A, did not accumulate β-catenin in response to Fc-ephrin-B2 (10 µg/mL for 24 hours), 
in contrast to naïve or empty vector control NSCs (CTL NSCs). (d) Constitutive degradation 
of β-catenin in GSK3 βS9A NSCs decreased NSCs differentiation into βIII-Tubulin+ 
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neurons in response to Fc-ephrin-B2 (10 µg/mL) vs. empty vector control NPCs (CTL 
NPCs) (n = 3 experimental replicates). (e) The lack of β-catenin signaling in GSK3 βS9A 
NSCs also nullified the proneuronal effect of hippocampus-derived, ephrin-B2 expressing 
astrocytes in co-culture (n=4, experimental repeats). (f) In mice co-infected with Tcf-Luc 
and dnWnt-IRES-GFP constructs, cells in the SGZ still expressed active β-catenin (ABC) 
and Luciferase (arrowheads) 24 hours after Fc-ephrin-B2 injection. Scale bar represents 100 
µm. (g) In hippocampi co-infected with Tcf-Luc and either dnWnt-IRES-GFP or IRES-GFP 
construct, then injected with Fc-ephrin-B2 or PBS, Fc-ephrin-B2 increased the percentage of 
SGZ BrdU+ cells with active β-catenin signaling 24 hours post-injection and the percentage 
of DCX+/BrdU+ cells by day 5 even with dnWnt present (n=4 brains, 8 sections per brain). 
Ephrin-B2 thus activates β-catenin signaling and enhances adult neurogenesis independent 
of Wnt signaling. * indicates P <0.01; ** indicates P <0.05; ± s.d; dotted vs. dashed lines 
mark SGZ/Hilus vs. GCL/MCL boundaries. Full length blots in Supplementary Fig. 9.
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